Thaci, D., A. Menter, J. J. Wu, D. Arikan, H. Kupper, M. Bereswill, and W. C. Valdecantos. “Long-Term Safety and Effectiveness of Adalimumab for Moderat-to-Severe Psoriasis: Results from the Eight-Year Interim Analysis of the ESPIRIT Registry”. SKIN The Journal of Cutaneous Medicine, vol. 1, no. 3.1, Oct. 2017, p. s22, doi:10.25251/skin.1.supp.21.